Eiger BioPharmaceuticals, Inc. (EIGRQ)
Eiger BioPharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on the development of innovative therapies for rare metabolic diseases. It is also developing avexitide as a treatment for Post-Bariatric Hypoglycemia. The company was founded by David A. Cory and Glenn S. Jeffrey on November 6, 2008 and is headquartered in Palo Alto, CA.
Address
2155 PARK BOULEVARD
PALO ALTO, CA 94306
Founded
2008
Number of Employees
25
Website
http://www.eigerbio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at EIGRQ make a trade.
Creating a free account takes less than one minute